Peter A. Ljubenkov

Neurology

1651 4th St Ste 212
San Francisco, CA 94158

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 50 publications

Reduced diffusion associated with amyloid-related imaging abnormalities in three patients treated with donanemab.

Reduced diffusion associated with amyloid-related imaging abnormalities in three patients treated with donanemab.

Journal: Neurocase

Published: July 02, 2026

Clinical Associations of Cerebrospinal Fluid TMEM106B in Familial and Sporadic Frontotemporal Dementia.

Clinical Associations of Cerebrospinal Fluid TMEM106B in Familial and Sporadic Frontotemporal Dementia.

Journal: JAMA neurology

Published: June 22, 2026

Arterial Spin-Labeling MRI at the Cortical-CSF Interface: A Novel Biomarker in Alzheimer Disease.

Arterial Spin-Labeling MRI at the Cortical-CSF Interface: A Novel Biomarker in Alzheimer Disease.

Journal: Annals of clinical and translational neurology

Published: May 04, 2026

Considerations for using amyloid-targeting therapies for the treatment of early symptomatic Alzheimer's disease.

Considerations for using amyloid-targeting therapies for the treatment of early symptomatic Alzheimer's disease.

Journal: Frontiers in neurology

Published: April 23, 2026

Continuous At-Home Monitoring of Nighttime Bed Behavior in Frontotemporal Dementia.

Continuous At-Home Monitoring of Nighttime Bed Behavior in Frontotemporal Dementia.

Journal: Neurology open access

Published: April 16, 2026

Factors influencing accelerated progression in behavioral variant frontotemporal dementia.

Factors influencing accelerated progression in behavioral variant frontotemporal dementia.

Journal: Journal of neurology

Published: January 07, 2026

Development and validation of the TabCAT-EXAMINER: A tablet-based executive functioning battery for research and clinical trials.

Development and validation of the TabCAT-EXAMINER: A tablet-based executive functioning battery for research and clinical trials.

Journal: Journal of the International Neuropsychological Society : JINS

Published: October 30, 2025

Early onset rapidly progressive frontotemporal dementia due to a novel MAPT P301A variant with functional validation of pathogenicity.

Early onset rapidly progressive frontotemporal dementia due to a novel MAPT P301A variant with functional validation of pathogenicity.

Journal: NPJ dementia

Published: October 18, 2025

Blood-based Alzheimer's disease biomarkers in a behavioral neurology clinic: Real-world implementation, clinical utility, and diagnostic performance.

Blood-based Alzheimer's disease biomarkers in a behavioral neurology clinic: Real-world implementation, clinical utility, and diagnostic performance.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: July 17, 2025

Author Correction: Large-scale network analysis of the cerebrospinal fluid proteome identifies molecular signatures of frontotemporal lobar degeneration.

Author Correction: Large-scale network analysis of the cerebrospinal fluid proteome identifies molecular signatures of frontotemporal lobar degeneration.

Journal: Nature aging

Published: July 07, 2025

Plasma lipidome dysregulation in frontotemporal dementia reveals shared, genotype-specific, and severity-linked alterations.

Plasma lipidome dysregulation in frontotemporal dementia reveals shared, genotype-specific, and severity-linked alterations.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: May 19, 2025

Changes of a Cerebral Cavernous Malformation Associated With Lecanemab Therapy in a Patient With Alzheimer Disease.

Changes of a Cerebral Cavernous Malformation Associated With Lecanemab Therapy in a Patient With Alzheimer Disease.

Journal: Neurology. Clinical practice

Published: March 01, 2025

Showing 1-12 of 50

Last Updated: 09/26/2026